Patent ID: 11919953
Assignee: AMGEN INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  Y | IPC A  C

Claim 2:
3. A CD112R antigen-binding protein comprising a HC and LC comprising the amino acid sequences selected from the group consisting of: (a) SEQ ID NOs: 9-10, respectively; (b) SEQ ID NOs: 19-20, respectively; (c) SEQ ID NOs: 29-30, respectively; (d) SEQ ID NOs: 39-40, respectively; (e) SEQ ID NOs: 49-50, respectively; (f) SEQ ID NOs: 59-60, respectively; (g) SEQ ID NOs: 69-70, respectively; (h) SEQ ID NOs: 79-80, respectively; (i) SEQ ID NOs: 89-90, respectively; (j) SEQ ID NOs: 99-100, respectively; (k) SEQ ID NOs: 229-230, respectively; (l) SEQ ID NOs: 1969-1970, respectively; (m) SEQ ID NOs: 1979-1980, respectively; (n) SEQ ID NOs: 1989-1990, respectively; (o) SEQ ID NOs: 1999-2000, respectively; (p) SEQ ID NOs: 241-242, respectively; (q) SEQ ID NOs: 247-248, respectively; (r) SEQ ID NOs: 249-250, respectively; (s) SEQ ID NOs: 251-252, respectively; and (t) SEQ ID NOs: 263-264 respectively.